This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Stemnion, Inc.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Christopher A Fried: Innovator in Bone Regeneration
Introduction
Christopher A Fried is an accomplished inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of regenerative medicine, particularly in bone growth and repair. His innovative work has the potential to impact various medical applications.
Latest Patents
Christopher A Fried holds a patent for a cell-derived composition known as Amnion-derived Cellular Cytokine Solution-B (ACCS-B). This invention is directed to a cell-derived composition that promotes bone growth, regeneration, and repair. The composition is designed to enhance the body's natural healing processes, making it a valuable asset in regenerative medicine.
Career Highlights
Fried is associated with Stemnion, Inc., a company focused on developing advanced cellular therapies. His work at Stemnion has allowed him to explore the therapeutic potential of cellular compositions in promoting bone health. With a patent portfolio that includes 1 patent, he continues to push the boundaries of innovation in his field.
Collaborations
Some of his notable coworkers include Malcolm A Meyn, III and Donna M Olejniczak. Their collaborative efforts contribute to the advancement of research and development in cellular therapies.
Conclusion
Christopher A Fried is a notable inventor whose work in bone regeneration through innovative cellular compositions holds promise for future medical advancements. His contributions to the field are paving the way for new therapeutic options in regenerative medicine.